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Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a chronic, progressively debilitating condition that is
prevalent in the US and worldwide. Patients suffer from progressive dyspnea and exercise intolerance. Physical
exercise is beneficial, but conventional pulmonary rehabilitation programs are underutilized. There remains a need
for novel interventions that improve symptoms, quality-of-life, and functional capacity. Tai chi is an increasingly
popular mind-body exercise that includes physical exercise, breathing training, mindful awareness, and stress
management–components that are essential to the self-management of COPD. There are, however, limited data on
the effectiveness of tai chi as a therapeutic intervention in this population.
Methods/Design: The Primary Aims are to evaluate the efficacy, safety, and feasibility of a 12-week tai chi program
for patients with COPD. We utilize a randomized controlled trial design, with participants assigned in a 2:1 ratio to
either a group tai chi program (N = 63) or a time/attention-matched education control (N = 31). Our primary outcomes
are COPD-specific quality-of-life and exercise capacity. Secondary outcomes include dyspnea, mood, functional status,
self-efficacy, and lung function. Cardiopulmonary exercise testing is done in a subset of patients (N = 50). To explore
optimal training duration, a subgroup of patients in tai chi are randomly assigned to complete an additional 12 weeks
training (total 24 weeks) (Exploratory Aim 1). To explore the impact of a simplified seated intervention including only a
subset of tai chi’s training components, a third randomly assigned group (N = 31) receives a 12- week mind-body
breathing program (N = 31) (Exploratory Aim 2).
Discussion: Results of the BEAM study (Breathing, Education, Awareness, Movement) will provide preliminary evidence
regarding the value of tai chi for improving quality of life and exercise capacity in patients with COPD, including
information regarding optimal duration. They will also inform the feasibility and potential benefit of an alternative
mind-body breathing intervention, and provide insight regarding how isolated mind-body exercise components
contribute to the overall effects of tai chi. Should the results be positive, tai chi and related mind-body practices
may offer a novel exercise option that is potentially accessible to a large proportion of patients with COPD.
Trial registration: This trial is registered in Clinical Trials.gov, ID number NCT01551953. Date of Registration
March 1 2012.
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Chronic obstructive pulmonary disease (COPD), a pro-
gressive syndrome of airflow limitation [1], is a major
cause of morbidity and mortality. In the US, it is the
third most common cause of death, and is the only
major disease among the top ten that continues to in-
crease in prevalence [2]. In 2011, almost 13 million
adults in the US were diagnosed with COPD, although
close to 24 million have impaired lung function, indicat-
ing under-diagnosis [3,4].
Despite advances in pharmacologic and surgical ther-
apy, patients suffer from dyspnea and have substantial
limitations in daily activities. Airflow limitation puts the
respiratory muscles at a mechanical disadvantage, in-
creasing the work of breathing and worsening exercise
tolerance. COPD also has systemic consequences with
increased oxidative stress and systemic inflammation,
contributing to skeletal muscle dysfunction and atrophy
.
In addition, persons with COPD are significantly less ac-
tive than healthy persons [2] even at the earliest stages
of disease [5,6]. In persons with COPD, decreased physical
activity is associated with increased levels of systemic
inflammation and increased risk of hospital admissions,
acute exacerbations, and death, independent of lung
function [7-10].
Moreover, anxiety and depression are prevalent among
these patients [11], which can become additional barriers
to participating in exercise and overall self–efficacy.
Novel interventions that address complex, biopsychoso-
cial issues of COPD and promote physical activity, could
potentially improve symptoms, health-related quality-of-
life (HRQL), functional capacity, and modify disease pro-
gression [2,12].
Complementary and integrative forms of exercise, such
as tai chi, have gained popularity in the general popula-
tion to promote health. Tai chi (tai chi chuan or taiji-
quan), is a multicomponent gentle, mind-body exercise
that has its roots in ancient Chinese martial arts. It
employs regimens of flowing circular movements that
integrate balance, flexibility, strength, and breath train-
ing, along with multiple cognitive tools (for example, fo-
cused internal awareness, positive imagery) [13,14]. Tai
chi’s role in conventional medical management of chronic
disease is poorly understood.
Studies have investigated tai chi exercise for a variety
of medical diseases including cardiovascular conditions
(for example, coronary artery disease [15], heart failure
[7,16-18], hypertension [19,20]), fall prevention and
neuromuscular control [21-26], pain and rheumatological
conditions [27-29], and cognitive function and psycho-
logical wellbeing [30,31]. These studies support its poten-
tial health benefits and safety for chronic health conditions,
and show promise as a novel, alternative, low-cost inter-
vention for prevention and rehabilitation [32,33].
There have been few studies examining tai chi exercise
specifically in patients with COPD. Recent meta-analyses
suggest potential benefits for multiple outcomes includ-
ing 6-minute walk distance, measures of dyspnea, spiro-
metric indices, and quality of life. However, the evidence
to date is preliminary and inconclusive due to small
samples sizes and methodological flaws [34,35]. More-
over, the majority of these studies have been conducted
in Asia, and generalizability of these results to ethnically
diverse Western populations is unclear.
This clinical investigation, the BEAM study (Breathing,
Education, Awareness, Movement), expands current know-
ledge of the potential efficacy of tai chi as an intervention
for improving quality of life and exercise capacity in pa-
tients with COPD. First, this study is a rigorous investiga-
tion in a Western population utilizing a novel intervention
protocol. Second, it provides an important evaluation of
dosage and optimal duration of tai chi. Third, the study
preliminarily investigates an alternative, simplified mind-
body breathing (MBB) intervention that isolates breathing
and meditative subcomponents of the tai chi intervention.
Results of this study will both provide information about
the relevance of these components in an overall tai chi pro-
gram and also evaluate MBB as an alternative meditative
intervention. Collectively, the BEAM study addresses key
gaps in current COPD care by evaluating a potentially safe,
modality of physical activity that is enjoyable, easily access-
ible, may lead to longer-term adherence, and become read-
ily incorporated into COPD self-management plans.
Tai chi components relevant to COPD
Tai chi is a multicomponent intervention that integrates
a number of training elements that are relevant to the
treatment of patients with COPD [33,36]. Key elements
included in our protocols include 1) physical exercise, 2)
respiratory muscle training and breathing techniques,
and 3) mindful awareness (Figure 1).
Physical exercise
The importance of exercise in the management of pa-
tients with COPD has been well studied, although there
is ongoing debate regarding the optimal types, intensity,
and duration of exercise [37-44]. Conventional exercise
programs, both high- and low-intensity (such as walking,
cycle ergometer, strength training), have been shown to
improve exercise endurance, shortness of breath, and
quality of life, even in patients with severe disease and
poor exercise tolerance [45]. Most studies support that
exercise leads to skeletal muscle adaptation, allowing
more work to be performed.
Exercise may also desensitize patients to dyspnea. In
addition, studies have suggested that unsupported upper
extremity exercise (for example, against gravity) may
offer additional benefits and effectively train patients in
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quired in daily living [39,46,47]. Although conventional
pulmonary rehabilitation programs have been shown to
be beneficial, only a small percentage of patients eligible
for such programs actually participate and maintenance
of physical activity is an ongoing challenge [48]. Alterna-
tive exercise options that are easily implemented, and
that promote long-term adherence and self-efficacy, are
much needed.
Tai chi provides mild aerobic activity, core strength
training, and lower extremity and unsupported upper
extremity training. The physical activity of tai chi is
estimated to be mild-moderate aerobic exercise, at 1.6 to
4.6 metabolic equivalents (METs) and 50 to 74% max-
imal heart rate, depending on the age of the individual
and the intensity of practice [49,50]. Previous literature
suggests that it is safe in patients with chronic disease,
including COPD, chronic heart failure, coronary artery
disease (recovering from bypass surgery and myocardial
infarction), as well as frailty, arthritis, and vestibular dis-
ease [51-53]. Studies also suggest that tai chi is access-
ible, enjoyable and has high rates of adherence; multiple
comparative effectiveness studies have reported higher
adherence to tai chi than the comparison group or exer-
cise. Tai chi may provide a suitable range of exercise for
those initiating physical activity or those transitioning to
higher levels of activity, or as an adjunct to other forms
of conventional activity.
Respiratory muscle training and breathing techniques
In COPD, respiratory muscle weakness and inefficiency
contributes to breathlessness, and exercise impairment.
Respiratory muscle training selectively works the inspira-
tory muscles to perform against loads, thereby increasing
strength, endurance, and efficiency. Studies in patients
with various respiratory disease, including COPD, have
reported improvements in inspiratory muscle function
(maximal inspiratory pressure), exercise performance (walk
distance), and dyspnea related to daily activities [54-56].
Similarly, breathing retraining in COPD aims to teach
patients to breathe more efficiently, replacing rapid shal-
low breathing patterns that may worsen gas exchange
with slower breathing patterns that improve chest wall
mechanics, allow more complete expiration, and de-
crease air trapping. Conventional breathing retraining,
such as diaphragmatic and pursed-lip breathing, may
improve symptoms, increase tidal volume and total ven-
tilation, decrease respiratory rate, and improve gas ex-
change [57-59]. In addition, slow, deep breathing can
also have beneficial effects on the autonomic nervous
system which is increasingly recognized as highly rele-
vant in COPD [60]. Studies in COPD patients have sug-
gested changes in sympathetic/parasympathetic balance
in indices such as heart rate variability [61].
Efficient, intentional and mindful breathing is a key
element of tai chi. The interventions employed in the
BEAM study include elements of respiratory muscle and
breathing retraining that similarly aim to increase
muscle strength and endurance, decrease mechanical
loads such as chest wall stiffness, and deepen and slow
the respiratory rate, thereby increasing gas exchange
efficiency. The MBB is taught and integrated within a
broader context of relaxation, focused self-awareness,
and imagery (see below), which may easily be adopted
by patients and facilitate translation into usual breathing
patterns during activities of daily life.
Potential mechanistic or mediating pathways
Stress Management
Pulmonary mechanics
Quality-of-life
Symptoms
Exercise capacity
Cardiopulmonary dynamics
Skeletal muscle function/conditioning
Mood Self-efficacy
Social support
*upper/lower extremity, core strengthening/stretching, 
dynamic structural integration
Physical 
Exercise*
Breathing 
Training
Mindful 
Awareness
Figure 1 Conceptual model of tai chi and mind-body breathing
and potential mechanistic pathways to improved patient-centered
outcomes in chronic obstructive pulmonary disease (COPD).
Physical activity, breathing training, and mindful awareness are the
key elements of tai chi relevant to COPD. The potential mechanistic
pathways through which tai chi may affect outcomes include
skeletal muscle conditioning, cardiopulmonary dynamics, pulmonary
mechanics, psychosocial factors (mood, self-efficacy, social support),
and stress management. Favorable changes in these domains may
then impact patient-centered outcomes of quality of life, symptoms,
and exercise capacity. The mind-body breathing intervention
contains similar key elements, although with less emphasis on
physical activity (for example, less aerobic and no lower extremity or
core strength training). The BEAM study includes the main patient-
centered outcomes as well as secondary measures (quantitative or
qualitative assessments) that inform each of the mechanistic pathways
depicted in the center oval.
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A fundamental component of tai chi is the deliberate at-
tention to bodily sensation, movement, breath, and emo-
tion, which fosters acute self-awareness, both physically
and emotionally. Participants learn, for example, to dis-
criminate areas with or without strain or tension, stron-
ger or weaker regions, movements that feel graceful or
fearful, or aspects of breathing that feel labored or un-
constrained. This awareness may in turn complement
other tai chi components that foster improved function
(for example, improved posture, relaxation). Recent stud-
ies support that mindfulness training can impact intero-
ceptive awareness of key COPD symptoms (such as
dyspnea and cough) which may lead to better symptom
management [62-64]. Inner awareness of moment-to-
moment sensations also helps develop focused attention,
providing a tool to manage distracting thoughts [65].
We hypothesize that increased awareness of postures
and breathing, and the psychophysiology of when dys-
pnea starts, will allow participants to better anticipate
and manage their symptoms, decreasing the risk of
worsening dyspnea and precipitating further breathing
difficulty and anxiety. This heightened mindfulness and
self-awareness of breathing, body shape, and emotion
may be important in facilitating change in pulmonary
patients who have developed maladaptive physical and
psychological patterns due to chronic dyspnea over time,
and lead to better symptom management [63]. In addition,
it is increasingly recognized that patients with COPD are
at high risk of developing symptoms of anxiety and de-
pression [66]. Anxiety over dyspnea-producing activities is
common and may promote maladaptive sedentary life-
styles [11]. Collectively, the mind-body approach of tai chi
inherently addresses stress management which is an
important component of COPD self-management.
Methods/Design
The BEAM study is a pilot randomized controlled trial
investigating tai chi exercise and MBB as an adjunct to
standard care in patients with COPD. We will enroll a
total of 125 participants, with participants randomized
in a 2:1 ratio to either a 12-week tai chi program (n =63) or
a time- and attention-matched education control (n=31).
Aims/hypotheses
The primary aims of this study are to evaluate the 1) ef-
ficacy and 2) safety and feasibility of a 12-week tai chi
mind-body exercise for patients with COPD. To explore
optimal training durations of tai chi, a subgroup of pa-
tients assigned to the tai chi program are randomly
assigned to complete an additional 12 weeks of training
(total 24 weeks) (Exploratory Aim 1). Additionally, to
explore the impact of an alternative simplified seated
intervention that includes a subset of tai chi training
components, a third randomly assigned group (n = 31)
receives a 12-week MBB program (n = 31) (Exploratory
Aim 2) (Figure 2).
Our primary efficacy outcomes are COPD-specific
quality-of-life (chronic respiratory questionnaire (CRQ))
and exercise capacity (6-minute-walk test). Secondary
outcomes examining further psychosocial and physio-
logical effects of tai chi include symptoms of dyspnea,
fatigue, mood, functional status, strength and flexibility,
self-efficacy, social support, and pulmonary function.
Cardiopulmonary exercise testing is also done in a
subset of patients (n =50). Safety and feasibility will be
assessed by successful recruitment and randomization,
adherence to the protocol and attendance at classes (at
least 70%), and demonstrated safety through systematic
adverse events (AE) monitoring and reporting.
We hypothesize that there will be improved patient-
centered outcomes (quality of life and exercise capacity)
in the tai chi group as compared to education control
and that the study will be feasible and safe in COPD.
Those who receive continued tai chi in phase 2 will have
increased 24-week adherence and improved outcomes.
There may be similar benefit in the MBB group in symp-
toms of dyspnea and psychosocial measures, but the tai
chi intervention will have trends towards more benefit
on exercise capacity, cardiopulmonary function, strength,
and flexibility.
Study population
Participants are being identified from the primary
care and pulmonary clinics at two primary institutions:
Beth Israel Deaconess Medical Center (BIDMC) and VA
Boston Healthcare System. Additional recruitment sites
include the pulmonary clinics at Brigham and Women’s
Hospital and Boston Medical Center. Recruitment strat-
egies include direct referral from physicians, and identi-
fication of eligible patients through hospital databases,
and mailings. All recruitment and data collection proce-
dures follow the Health Information Privacy and Ac-
countability Act (HIPAA) guidelines to maintain patient
confidentiality, and study procedures have been ap-
proved by each institution’s investigational review board.
A list of the institutions and ethical boards providing
approval is provided in Additional file 1.
Participants are eligible for the study if they: 1) have
moderate-severe COPD as defined by global obstructive
lung disease (GOLD) stage 2, 3, or 4, with symptoms of
dyspnea (either forced expiratory volume in one second
(FEV1) ≤80% and FEV1/forced vital capacity (FEV1/
FVC) <0.70, or evidence of emphysema on computed
tomography (CT); and 2) are aged ≥40 years.
Exclusion criteria are: 1) respiratory failure or GOLD
stage 4 and inability to safely perform a 6-minute walk
test or otherwise exercise safely as deemed by a
Yeh et al. Trials 2014, 15:337 Page 4 of 13
http://www.trialsjournal.com/content/15/1/337physician; 2) COPD exacerbation requiring steroids, an-
tibiotics, an emergency room (ER) visit or hospitalization
within the past 2 weeks unless the physician deems the
subject to be at clinical baseline; 3) planned thoracic
surgery within the next 3 months; 4) hypoxemia on the
walk test or cardiopulmonary exercise test (oxygen sat-
uration <88% on supplemental oxygen); 5) inability to
ambulate due to vascular or other neuromuscular condi-
tions that would preclude a walk test; 6) clinical signs of
unstable cardiovascular disease (that is, chest pain on
the walk test or electrocardiogram changes on the cardio-
pulmonary exercise test); 7) severe cognitive dysfunction
(mini-mental status exam score ≤24); 8) non-English
speaking; 9) current active participation in a pulmonary
rehabilitation program or current regular practice of tai
chi; and 10) physician diagnosis of unstable/untreated
clinical depression.
Informed consent
Written informed consent is obtained by the research
assistant at the initial visit. Patients are asked to partici-
pate in a study examining three types of intervention
involving exercise and/or education. In order to assess
credibility of the three groups and clinical equipoise
from the patient’s perspective, we employ an expectancy
and treatment credibility assessment from Borkovec and
Nau. This instrument provides a measure of how cred-
ible patients perceive a treatment to be, and has been
used in prior trials to assess blinding [67].
Randomization and allocation concealment
Randomization occurs after baseline testing. Participants
are randomized to one of three group classes: tai chi,
MBB, or education, in a 2:1:1 ratio. Group assignments
are generated by a permuted blocks method with randomly
Eligible subjects with COPD 
consented and enrolled (N= 125)
Baseline testing:
questionnaires, functional tests, PFTs, CPETT 
1
st Randomization
Primary Aim Exploratory Aim #2
12-week testing:
questionnaires, functional tests, PFTs, CPETT 
2
nd Randomization
Tai Chi only 
Exploratory Aim #1
Tai Chi Dosage
24-week testing; questionnaires, functional tests, PFTs, CPETT
Education
(N= 31) 
Tai Chi
(N= 63) 
Mind-Body 
Breathing (N= 31)
Usual Care 
(N=31)
Tai Chi 
‘Maintenance’
(N= 32) 
Usual Care            
(N= 31) 
Usual Care
(N= 31)
Figure 2 The BEAM study design. The primary aims of this randomized controlled trial are to evaluate the efficacy, safety and feasibility of a
12-week tai chi exercise program as compared to a time- and attention-matched education control. At 12 weeks, subjects in tai chi undergo a
second randomization to either continue with tai chi for an additional 12 weeks (total 24 weeks), or to receive usual care. (Exploratory Aim 1: Tai
Chi Dosage). To explore the impact of a simplified seated mind-body breathing intervention, a third randomly assigned group receives a 12-week
mind-body breathing program (Exploratory Aim 2). After the initial 12 weeks of both education and mind-body breathing, subjects receive usual
care for the following 12 weeks. All participants undergo testing at baseline, 12 weeks, and 24 weeks.
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lopes. Intervention classes begin within 3 weeks of baseline
testing. At the end of phase 1, participants in the tai chi
group undergo a second randomization to either continue
tai chi class once weekly, or to resume usual care. Partici-
pants are informed at baseline of the two randomization
processes and that the intervention may be either 3 or
6 months long.
Interventions
Tai chi, MBB, and education classes are conducted twice
weekly for one hour each for the first 12 weeks. In the
second 12 weeks of the study, participants in the tai chi
class may be assigned to continue tai chi classes once
weekly for an additional 12 weeks. Instructors who ad-
minister the tai chi and MBB interventions are senior tai
chi students and certified graduates of a 2.5-year in-
structor training program that includes training in medi-
tative breathing. The average training experience of the
four study instructors is 19 years.
Importantly, the tai chi instructors also administer the
education class to minimize the variability with respect
to instructor type, personality, and training. Chairs are
provided for seated warm-up, breathing exercises and
resting, as well as for stability as needed when perform-
ing standing tai chi exercises. Subjects in tai chi and
MBB groups receive a 45-minute video as well as a sep-
arate audio file of the exercises taught in class, and are
given detailed instruction about specific exercises, and
encouraged to practice outside of class three times a
week (for at least 30 minutes).
Tai chi intervention
The 12-week tai chi intervention has been specifically
designed for an older, physically limited population with
COPD. In brief, this protocol was modified from a simi-
lar intervention that was developed in prior studies in-
vestigating tai chi for chronic heart failure [7,68] and in
a pilot study of COPD patients [52].
We convened an expert panel with representation
from pulmonary medicine, exercise physiology, mind-
body medicine, tai chi, and clinical trial methodology.
We refined the intervention protocol using an iterative
modified Delphi process (details to be reported else-
where). In comparison to our intervention for persons
with heart failure, the current tai chi protocol further
emphasized the integration of multiple mindful breath-
ing techniques as well as the addition of two warm-up
exercises to improve awareness and flexibility of the
spine, rib cage and upper torso.
The intervention emphasizes essential tai chi move-
ments that are both easily comprehensible and can be
done repetitively in a flowing manner. The five tai chi
movements - ‘raising the power’, ‘withdraw and push’,
‘grasp the sparrow’s tail’, ‘brush knee twist step’, and
‘cloud hands’ - are based on the traditional Cheng Man-
Ch’ing’s Yang-style short form [13]. In addition to these
five core movements, the intervention includes a com-
plementary set of traditional tai chi warm-up exercises,
including specific MBB techniques. These warm-ups
focus on loosening the physical body, providing moder-
ate aerobic activity, incorporating mindfulness and im-
agery into movement, promoting overall relaxation of
body and mind, and generating awareness and efficiency
of breathing.
The MBB techniques included within the tai chi proto-
col are described below. All components of the MBB
intervention are included in the tai chi intervention.
Within the tai chi protocol, breathing components are
taught both in a seated position as in the MBB class, but
also integrated into moving tai chi and warm-up exer-
cises. We conclude each session with a brief cool-down
exercise of seated self-massage of the face, abdomen,
flanks, and mid-back.
Education control
The content of this class is based on information from
the American Thoracic Society, American College Chest
Physicians, and the Global Obstructive Lung Disease
Patient Guide [69-74]. Educational modules include:
anatomy of the lungs, COPD, managing COPD symp-
toms, smoking cessation, diagnostic tests, understanding
COPD meds, managing acute exacerbations, managing
stress, exercise, nutrition, sleep, mental health, oxygen
therapy, surgical options, pulmonary rehabilitation, and
advance care planning. Time is spent with both didactic
as well as informal group discussion moderated by the
instructor. The instructors have explicit instructions to
moderate discussions and not make any recommenda-
tions regarding an individual’s treatment.
MBB intervention
The MBB intervention is comprised of the breathing
techniques of the tai chi exercise program; however, all
techniques are performed in a seated position. This
intervention removes some elements of physical activity
(no aerobic activity, no lower extremity strengthening
and stretching, less core strengthening), while retaining
breathing and mindful awareness.
The overall goals of the breathing intervention are to
increase the efficiency of gas exchange, enhance aware-
ness/mindfulness of the mechanics of breathing, and
promote relaxation of both physical body and mind.
Four traditional inter-related techniques are taught;
detailed descriptions of these can be found in traditional
and modern tai chi and qigong publications [75-78].
1) renewing the body with breath is a simple relaxation
technique that employs the breath and imagery as a
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2) mindful breathing cultivates inner awareness of the
breath as air and its consequent internal pneumatic and
hydraulic pressures travel from the nostrils to the lower
abdomen, and back out; 3) ocean breathing emphasizes
diaphragmatic breathing and expansion and contraction
of the lower abdomen; and 4) balloon breathing empha-
sizes effortless inhalations and a prolonged exhalation
cycle relative to inhalation.
Each of the techniques was chosen to emphasize dif-
ferent aspects of MBB relevant to COPD rehabilitation.
The expectation is that over time these methods will
become integrated into usual breathing patterns during
daily activities. Subjects in class are explicitly taught to
incorporate the techniques into simple activities of daily
living (for example, while reading or talking on the
phone). The protocol also begins with the same
series of seated warm-up exercises that are employed
in the tai chi intervention that particularly target
awareness and flexibility of the upper torso and rib
cage. Subjects who complete all study requirements
have the option of joining a class of their choice
(one of the two groups to which they were not ran-
domized). These subjects do not undergo additional
testing but are monitored for AEs.
Primary measures
All research staff performing outcome testing are blinded
to participants’ intervention allocations. Table 1 details the
schedule of evaluations.
Six-minute walk test
This is a standardized assessment that measures the
maximum distance walked in 6 minutes [79]. Subjects
are read standardized, scripted instructions and informed
when there are 3 minutes and 1 minute before the end
of the test. Subjects are allowed to stop as often as they
need and to use supplemental oxygen if usually prescribed
for activity. The 6-minute walk test has been shown to
be an independent correlate of COPD prognosis and
survival [80,81].
Disease-specific HRQL measure
The main HRQL measure is the disease-specific chronic
respiratory disease questionnaire (CRQ). This validated
instrument is one of the most commonly employed
health status measures for COPD. It consists of 20 items
covering four domains - dyspnea, fatigue, emotional
function and mastery. Items are scaled on a 7-point
modified Likert scale, with higher scores indicating better
HRQL [82]. We use the self-administered, standardized
Table 1 Schedule of evaluations
Outcome Measurement/instrument Month
01 22 4
Physical functioning
Exercise capacity 6-minute walk test (6 MW)* XX X
Bicycle cardiopulmonary exercise test**
Strength/flexibility Chair sit and reach X X X
Chair stand
Physical function PROMIS physical function X X X
Health-related quality-of-life and symptoms (HRQL)
COPD-specific HRQL Chronic respiratory disease questionnaire (CRQ)* XX X
Dyspnea UCSD shortness of breath questionnaire; X X X
MMRC dyspnea scale
Fatigue PROMIS fatigue X X X
Psychosocial functioning and support
Self-efficacy COPD self-efficacy scale X X X
Mood Center for epidemiologic studies-depression scale (CES-D) X X X
Stress Perceived stress scale X X X
Perceived social support Multidimensional scale of perceived social support X X X
Pulmonary function
Spirometry and lung volumes Standard pulmonary function tests X X X
*Primary measures. **Cardiopulmonary exercise test (n= 50) will be done in a subset of patients. PROMIS, Patient-Reported Outcome Measurement Information
System; COPD, chronic obstructive pulmonary disease; UCSD, University of California, San Diego; MMRC, Modified Medical Research Council.
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lated by the sum of individual responses divided by the
number answered (mean response).
Secondary measures
Cardiopulmonary exercise test
In a random subset (n = 50 total), participants perform a
symptom-limited exercise test using a bicycle ramp
protocol to determine peak oxygen uptake (VO2) and
exercise endurance. Testing is done on an electronically
calibrated upright bicycle, with expired gas analysis under
continuous electrocardiographic monitoring. Breathless-
ness and leg fatigue are measured using the Borg scale of
1 to 10 during the test. Breath-by-breath respiratory gas
analysis is performed using a SensorMedics (Yorba Linda,
CA, USA) metabolic cart. Peak values are averaged from
the final 20 seconds of the test. Peak VO2 has been shown
to correlate with cardiac output and skeletal muscle blood
flow and predict mortality in COPD [83].
Strength and flexibility
The chair stand test assesses lower body strength and
endurance. Subjects are instructed to rise to a full stand-
ing position and then return to a seated position with
arms folded across their bodies as many times as pos-
sible within 30 seconds. This validated test has been
used in numerous populations with age and gender spe-
cific normative data available [84]. The chair sit and
reach assesses lower body flexibility, primarily the ham-
string, and is a modification of the original sit and reach,
developed for use in older or deconditioned populations
to decrease risk of injury in those with back pain or
limited range of motion [85].
Dyspnea
The University of California, San Diego (UCSD) shortness
of breath questionnaire is a 24-item self-administered in-
strument that assesses the degree to which patients feel
short of breath while performing 21 different activities of
daily living. Respondents rate symptoms on a 6-point scale
from not at all to maximally or unable to do because of
breathlessness [86]. The Modified Medical Research
Council (MMRC) dyspnea scale is a 4-point scale asses-
sing dyspnea severity, with a score of 4 indicating that
the patient is too breathless to leave the house or
becomes breathless when dressing or undressing. This
scale predicts the likelihood of survival among patients
with COPD and correlates well with other scales and
health status scores [87]. This scale is one of the four
components of the body mass: airflow obstruction: dys-
pnea: exercise capacity (BODE) index, a validated multi-
dimensional grading system for COPD that has been
shown to be a better predictor of mortality than FEV1
alone [88].
Self-efficacy
The COPD self-efficacy scale (CSES) was developed to
identify situations during which patients with COPD
lack confidence in their ability to manage or to avoid
breathing difficulties. The situations include times of
negative affect (when I feel down or depressed), intense
emotions, physical exertion, at-risk behaviors (when I
overeat), or adverse weather/environmental conditions.
Patients rate the level of confidence they feel, ranging
from not confident at all to very confident, in managing
or avoiding breathing difficulties during 24 different situ-
ations. The CSES has high internal consistency (r=0.95)
and test-retest reliability (r= 0.77) [89].
Emotional status/mood
The Center of Epidemiology Studies-depression scale
(CES-D) is a general measure of psychological impair-
ment, primarily depressive symptoms, that has been used
extensively in epidemiology studies [90]. It is a validated
instrument consisting of 20 items, including feelings of
depression, worthlessness, loneliness, energy level and
fear. Participants are asked to report how often they expe-
rienced the symptom during the past week using a 4-point
ordinal scale (rarely or none of the time; some or little of
the time (1 to 2 days); occasionally or moderate amount
of the time (3 to 4 days); most or all of the time (5 to
7 days). A score <15 indicates no depression. The CES-D
has high internal consistency (r =0.90) and a test-retest
reliability of 0.51 [91,92].
Physical function and fatigue
We use the PROMIS Physical Function-Short Form 10a
questionnaire to track patients’ physical functioning, and
the PROMIS Fatigue Short Form 7a to track patients’
fatigue. The Patient-Reported Outcome Measurement
Information System (PROMIS®) instruments funded by
the National Institutes of Health are based on modern
measurement theory and include the application of
mixed methods approaches for instrument development.
Both forms are short validated instrument with seven to
ten items, each with five response options on an ordinal
scale (not at all, a little bit, somewhat, quite a bit, very
much) [93,94].
Perceived stress and social support
The perceived stress scale is a measure of the degree to
which situations in one's life are appraised as stressful.
We will use the 10-item version of this instrument
which we have used in our prior tai chi trials and which
has been shown to have good reliability and validity [95].
The multidimensional scale of perceived social support
is a validated instrument that will be used to assess the
degree of perceived social support provided in each
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family, friends, and significant others [96].
Pulmonary function tests
Spirometry and lung volume measurements will be per-
formed using rolling-seal volume displacement spirome-
ters (Collins CPL Raptor, Louisville, CO, USA),
following American Thoracic Society standards for qual-
ity and reproducibility [97]. Lung volumes are performed
via plethysmography. Lung volumes, such as total lung
capacity (TLC) and functional residual capacity, add in-
formation about hyperinflation from COPD that may
negatively affect respiratory muscle function. The
inspiratory-to-total lung capacity ratio (IC/TLC) may be
a particularly useful index of resting airflow limitation
and lung hyperinflation that correlates with exercise cap-
acity [98].
Other data collection
Physical activity
To track participants’ level of physical activity outside of
exercise classes, we use the Community Health Activ-
ities Model Program for Seniors (CHAMPS) physical ac-
tivity questionnaire for older adults [99]. CHAMPS is a
41-item validated instrument in the elderly, which covers
physical activity from several domains, including leisure,
household, and occupational. Weekly frequency and
total time spent allows estimation of caloric expenditure.
In addition, we use the Moy physical activity checklist
specifically to measure activity in patients with COPD
[100]. A higher number of daily checklist activities per-
formed is associated with better indices of COPD health,
including higher FEV1 and lower BODE index.
Qualitative interview
We also perform semi-structured qualitative exit inter-
views with participants in all groups to further explore
areas not captured in our standardized quantitative in-
struments. Questions probe participants’ experiences
with the program overall; changes in physical, mental, or
social function specific to the intervention; changes in
illness perception; experiences with practicing the inter-
vention; and expectations and beliefs about mind-body
therapies. These open-ended questions may yield add-
itional insights into understanding the mechanism of a
mind-body exercise program. Each interview session is
audio recorded, then transcribed verbatim.
Adherence
Adherence is defined as greater or equal to 70% of inter-
vention classes attended. During phase 1 in the first
12 weeks, compliance with home practice in the tai chi
and MBB arms is tracked through home practice logs
that are completed at each class. During phase 2 in the
second 12 weeks, those not randomized to continued
classes are queried about home practice once a month
by phone.
Safety and adverse event monitoring
Interview data are used to document patients’ use of
health care during the study period. Medical record re-
view is conducted for details of hospitalizations for AE
reporting. At each testing visit at baseline, 12 and
24 weeks, we ask specifically about medical symptoms in
the past 12 weeks such as muscle strain, fainting/loss of
consciousness, dizziness, worsening shortness of breath
or COPD exacerbation, worsening fatigue, falls, palpita-
tions, psychological stress, or other AEs. For any symp-
tom ascertained, we further document the patient’s
perception of relatedness to the intervention or testing,
severity, any required change in medications, and any
further medical care, hospitalization or ER visit. For hos-
pitalizations and ER visits, we further ascertain discharge
diagnosis and results of major cardiopulmonary tests or
procedures performed. During the intervention, occur-
rences of adverse events are also queried by instructors
and captured in the attendance log, which subjects
complete during each class. If a potential AE is reported,
study staff contact the participant for further details to
determine if a reportable AE has occurred and if so,
document the type, whether expected or not, relatedness
to the study, and severity. Serious AEs are defined ac-
cording to our institutional review board’s policy to be
an event that is life-threatening, requires hospitalization,
results in persistent or significant disability/incapacity or
death. Incidents are reported to the IRB, our sponsor,
and our Data Safety and Monitoring Board (DSMB) as
appropriate.
Statistical analysis
Sample size and power
This study is powered on our pre-specified primary out-
comes of overall CRQ (chronic respiratory question-
naire) score and 6-minute walk-test distance. Our effect
estimates and standard deviations are based on pilot
data of 12-weeks of tai chi versus usual care in patients
with COPD [52]. Enrollment of 125 participants will
provide approximately 93% power to detect differences
between groups of approximately 50 meters change in
the 6-minute walk test and 0.9 point change in total
CRQ score (mean response value). Our primary com-
parison will be between the tai chi and education
groups, from baseline to 12 weeks in phase 1. It is widely
accepted that a change in the 6-minute walk test of 54
meters is clinically significant [81,101-104]. For the
CRQ, Redelmeir et al. reported that a 0.5 point change
is clinically meaningful [104]. Our study has over 96%
power to detect a difference of 54 meters and 99% power
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served in our pilot). These calculations allow for a 5%
loss of statistical efficiency of the nonparametric test
compared to a t-test (for the 6-minute walk), 10% drop-
out rate, and a conservative Bonferroni correction for
multiple outcomes.
For our exploratory dosage aim, we expect to have
about 82% power to detect differences between groups
of a 50-meter change in 6-minute walk and 0.9 point
change in total CRQ. This sample size of 21 per group
(12 weeks versus 24 weeks of tai chi) accounts for a 5%
loss of statistical efficiency. We expect to have limited
power for our second exploratory aim comparing tai chi
to the MBB group.
Prior to analyzing the outcomes, we will examine base-
line demographic, functional, and clinical variables as
well as known prognostic factors (such as baseline GOLD
stage and baseline peak VO2)b yr a n d o m i z e dg r o u p .O u r
primary analyses will examine changes between baseline
and 12 weeks.
Primary aims
Efficacy Changes in total scores on the CRQ will be an-
alyzed using analysis of covariance (ANCOVA), compar-
ing the change from baseline to 12 weeks among the
two treatment groups tai chi versus education, adjusted
for the baseline value of the outcome (and, if necessary,
baseline characteristics found poorly balanced between
groups). For the 6-minute walk, the change from baseline
to 12 weeks is known to be skewed, so we will use a non-
parametric approach and use a Wilcoxon rank sum test to
compare the two treatment groups at α=0. 05 (w it ho ut
the Bonferroni correction, given the pilot feasibility nature
of the study). As complements to these main approaches,
we may use bootstrap analysis to evaluate confidence
intervals and the cumulative distribution function with
evaluation of the area under the curve for each study arm
to show the distribution of patients who improve.
Safety/feasibility Study feasibility will be established if
we can report that a reasonable proportion of eligible
patients are willing to participate (>10%), that we can re-
cruit participants at a reasonable rate (approximately 5
patients per month), and that patients once enrolled will
adhere to our study protocol (with at least 70% attend-
ance). Safety will be evaluated through descriptive statis-
tics of AEs and frequencies will be reported per type
according to grade and severity per arm. The interven-
tion will be considered safe if there are no serious AEs
related to the intervention.
Secondary aims
The basic analytic approach for secondary efficacy mea-
sures will be parallel to the approach for the primary
measures, comparing change in outcome from baseline
to 12 weeks among the two treatment groups. However,
for these secondary measures, we do not anticipate using
an adjustment for multiple outcomes. As secondary ana-
lyses, we also plan to analyze the change in each of the
four CRQ subdomains (dyspnea, fatigue, emotion, mas-
tery) using the same methods.
In addition, we will use linear regression models using
primary study outcomes (change in 6-minute walk and
CRQ score) as dependent variables and scores on psy-
chosocial assessments and functional tests as potential
mediators to examine whether clinical outcome is asso-
ciated with these psychosocial or physiological parame-
ters. Separate exploratory models will be developed for
each primary outcome, providing insight into potential
mechanisms of effect.
Qualitative exit interviews will be professionally tran-
scribed from audio recordings and coded using an induct-
ive approach informed by grounded theory methods. We
will identify passages in the transcripts that represent
common themes or content categories relating to positive,
negative, and neutral aspects of patients’ experiences with
tai chi, MBB, and education control. Data will be analyzed
and presented descriptively according to content cat-
egories (as above) [105-108]. We will also examine a
per-protocol analysis of our primary outcomes for aim
1, where non-adherers will be excluded (secondary ana-
lysis). Non-adherence will be defined as attendance at
less than 70% of classes.
Exploratory aim 1 (dosage) With respect to examining
dosage of tai chi, we will compare the change in all out-
comes between the two tai chi groups (12-week versus
extended 24-week intervention) using ANCOVA and the
Wilcoxon rank sum test as appropriate, similar to our
primary aims. We will further assess adherence to the
continued classes from 12 to 24 weeks. We will also
analyze home practice hours (in both groups), and total
practice hours (class plus home practice in the 24-week
class group) and compare groups using the Wilcoxon
rank sum test. Clinical data obtained through patient
interview will be analyzed using descriptive statistics.
Particularly in the intervention groups, we will de-
scribe patient attendance at classes and compliance with
home practice, and examine whether compliance or
dosage is associated with clinical outcome.
Exploratory aim 2 (MBB) We will obtain the point esti-
mates for the change in outcomes, that is, mean change
in CRQ and median change in the 6-minute walk be-
tween baseline and 12 weeks in the MBB group. We
expect these means/medians to be intermediate between
changes in the tai chi group and changes in the educa-
tion group. Even though we are not powered to detect
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analyses to gather preliminary estimates of effect. We will
use ANCOVA and Wilcoxon rank sum tests, similar to the
first aim, to compare change in the CRQ and the 6-minute
walk, between the MBB group and education, and between
the MBB group and tai chi. We will establish overall feasi-
bility and adherence of the MBB group by assessing will-
ingness to participate and attendance at classes.
Summary/Discussion
Results of this innovative study will establish feasibility
and provide preliminary evidence on the efficacy of tai
chi exercise to improve quality of life and exercise cap-
acity in patients with COPD. In addition, we will capture
information on potential physiological and psychosocial
mechanistic pathways. The development and exploration
of a seated intervention that emphasizes meditative
breathing provides further insight into mechanisms of
tai chi by isolating relevant elements of the larger, multi-
component intervention. Finally, the extension of inter-
vention duration from 12 to 24 weeks will help to
inform issues of optimal dosage for this population.
Trial status
This study is currently ongoing with active recruitment.
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